| 中國醫藥大學 |
2009-10 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳建宇(Chien-yu CHEN);(Yea-huey CHANG);包大靝(Da-Tian Bau);黃泓縉(Hung-jin HUANG);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Prenatal diagnosis of mos45,X/46,X,+mar in a fetus with normal male external genitalia and literature review
|
簡淑錦(Shu-Chin Chien); (Chih-Ping Chen); 林齊強(Chyi-Chyang Lin); 黃莉佳(Li-Chia Huang); (Cheng-Tiao Hsieh); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-10 |
Discovery the inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
陳建宇(Chien-yu CHEN); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Association of TNF-α gene polymorphisms with systemic lupus erythematosus in Taiwanese patients
|
林應如(Ying-Ju Lin); 陳榮興(Rong-Hsing Chen); 萬磊(Lei Wan); 許晉銓(Jinn-Chyuan Sheu); 黃春明(Chung-Ming Huang); 林振文(Lin Cheng Wen); 陳世殷(Shih-Yin, Chen); 賴志河(Chih-Ho Lai); 藍郁青(Yu-Ching Lan); 薛凱中(Kai-Chung Hsueh); 蔡長海(Chang-Hai Tsai); 林亭旭(Ting-Hsu Lin); 黃佑民(Y-M Huang); 趙寬(K Chao); 陳大元(D-Y Chen); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-09 |
Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
|
羅婉瑜(Wan-Yu Lo); 鄭隆賓(Long-Bin Jeng)*; 許維儀(Wei-Yi Hsu); 林瑋德(Wei-De Lin); 林炯璁(Chiung-Tsung Lin)*; 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-09 |
Pernatal diagnosis of partial trisomy 14q (14q31.1->qter) and partial monosomy 5p (5p13.2->pter) associated with polyhydramnios, a small thorax, short limbs, micropenis and brain malformations
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Chen-Chi Lee); (Li-Feng Chen); (Wayseen Wang) |
| 中國醫藥大學 |
2009-09 |
Concomitant craniorachischisis and omphalocele in a male fetus: prenatal magnetic resonance imaging findings and literature review
|
陳持平(Chih-Ping Chen)*; (Yu-Peng Liu); 蔡輔仁(Fuu-Jen Tsai); (Chen-Yu Chen); (Hung-Hung Lin); (Pei-Chen Wu); (Wayseen Wang) |
| 中國醫藥大學 |
2009-09 |
Prenatal diagnosis of and molecular analysis of triploidy in a fetus with intrauterine growth restriction, relative macrocephaly and holoprosencephaly
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Chin-Yuan Hsu); (Kevin Ko); (Wayseen Wang) |
| 中國醫藥大學 |
2009-09 |
Prenatal diagnosis of and molecular analysis of trisomy 13 mosaicism
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Hung-Hung Lin); (Chen-Wen Pan); (Wayseen Wang) |
| 中國醫藥大學 |
2009-09 |
Muscarinic Acetylcholine Receptor 1 Gene Polymorphisms Associated with High Myopia
|
林慧茹(Hui-Ju Lin); 萬磊(Lei Wan); 蔡育勳(Yuhsin Tsai); 陳汶吉(Chen, Wen-Chi); 蔡詩偉; 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-09 |
Akt mediates 17 -estradiol and/or estrogen receptor- inhibition of LPS-induced tumor necresis factor- expression and myocardial cell apoptosis by suppressing the JNK1/2-NF B pathway
|
(Chung-Jung Liu); (Jeng-Fan Lo); (Chia-Hua Kuo); (Chun-Hsien Chu); (Li-Ming Chen); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); (Bor-Show Tzang); 郭薇雯(Wei-Wen Kuo)*; 黃志揚(Chih-Yang Huang)* |
| 中國醫藥大學 |
2009-09 |
Prenatal magnetic resonance imaging, ultrasound imaging findings and genetic analysis of concomitant rhabdomyomas and cerebral tuberous sclerosis
|
陳持平(Chih-Ping Chen)*; (Yi-Ning Su); (Tung-Yao Chang); (Yu-Peng Liu); 蔡輔仁(Fuu-Jen Tsai); (Jonathan Kwei Hwang); (Wayseen Wang) |
| 中國醫藥大學 |
2009-08 |
Sclera-related gene polymorphisms in high myopia
|
林慧茹(Hui-Ju Lin); 萬磊(Lei Wan)*; 蔡育勳(Yuhsin Tsai); 劉素卿(Su-Ching Liu); 陳汶吉(Chen, Wen-Chi); 蔡詩偉; 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-08 |
Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats
|
郭薇雯(Wei-Wen Kuo); (Li-Ching Chung); (Cheng-Tzu Liu); (Shih-Ping Wu); (Chia-Hua Kuo); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); (Min-Chi Lu); 黃志揚(Chih-Yang Huang)*; 李信達(Shin-Da Lee)* |
| 中國醫藥大學 |
2009-08 |
Leu27IGF-II plays opposite role to IGF-I to induce H9c2 cardiomyoblast cell apoptosis via G{alpha}q signaling.
|
陳瑞杰(Ray-Jade Chen); (His-Chin Wu); (Mu-Hsin Chang); (Chao-Hung Lai); (Yun-Chen Tien); (Jin-Ming Hwang); (Wu-Hsien Kuo); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); (Li-Mien Chen)*; 黃志揚(Chih-Yang Huang)*; (Chun-Hsien Chu)* |
| 中國醫藥大學 |
2009-08 |
Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis
|
陳建宇(Chien-yu CHEN); (Yea-huey CHANG); 包大靝(Da-Tian Bau); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-08 |
Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis
|
陳建宇(Chien-yu CHEN); (Yea-huey CHANG); (Bau Da Tian); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-07-31 |
使用黃體激素受體基因的多形性,來找出骨盆器官脫垂危險因子的遺傳標記之研究。
|
陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-07-31 |
利用神經系統性疾病和果蠅動物模式研究學習與記憶之分子機制暨篩選有效之治療藥物
|
林維勇(Wei-Yong Lin); 蔡輔仁(Fuu-Jen Tsai); 郭煌宗(Haung-Tsung Kuo); 陳永祥(Yung-Hsiang Chen) |
| 中國醫藥大學 |
2009-07-31 |
生長激素受體CODON 440 G/T多型性的訊息傳導的研究
|
蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-07-31 |
多巴胺系統在妥瑞症合併過動與注意力不集中症之研究
|
周宜卿(I-Ching Chou); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai); 藍先元(Hsien-Yuan Lane); 李采娟(Tsai-Chung Li) |
| 中國醫藥大學 |
2009-07-31 |
妥瑞症,過動與注意力不集中症兒童,與正常兒童之行為與精神狀態與基因之研究
|
周宜卿(I-Ching Chou); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai) |
| 中國醫藥大學 |
2009-07 |
Progesterone receptor polymorphism is associated with pelvic organ prolapse risk
|
陳慧毅(Huey-Yi Chen); 鍾雅雯(Ya-Wen Chung); 林維勇(Wei-Yong Lin); 陳汶吉(Chen, Wen-Chi); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai) |
| 中國醫藥大學 |
2009-06-10 |
FOXL2 mutations in Taiwanese patients with blepharophimosis-ptosis-epicanthus inversus syndrome
|
周宜卿(I-Ching Chou); 林瑋德(Wei-De Lin); 李妮鐘(Ni-Chung Lee); 王仲興(Chung-Hsing Wang); 郭煌宗(Haung-Tsung Kuo); 蔡長海(Chang-Hai Tsai); 林炫沛(Shuan-Pei Lin); 趙美琴(Mei-Chyn Chao); 胡務亮(Wuh-Liang Hwu); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-06 |
Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-kB-dependent pathway
|
馮逸卿(Yi-Chin Fong); (Shan-Chi Liu); 黃俊寅(Chun-Yin Huang); 李德茂(Te-Mao Li); 許昇峰(Sheng-Feng Hsu); 高尚德(Shung-Te Kao); 蔡輔仁(Fuu-Jen Tsai); 陳汶吉(Chen, Wen-Chi); 陳志毅(Chih-Yi Chen); 湯智昕(Tang Chih-Hsin)* |
| 中國醫藥大學 |
2009-06 |
Activation of Insulin-Like Growth Factor II Receptor Induces Mitochondrial-Dependent Apoptosis through G{alpha}q and Downstream Calcineurin Signaling in Myocardial Cells
|
(Chun-Hsien Chu); (Bor-Show Tzang); (Li-Ming Chen); (Chung-Jung Liu); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 林子恩(Lin, Tzu-En); 包大靝(Da-Tian Bau)*; 姚俊旭(Chun-Hsu Yao)*; 黃志揚(Chih-Yang Huang)* |
| 中國醫藥大學 |
2009-06 |
Association of Interleukin-10 A-592C polymorphism in Taiwanese Children with Kawasaki disease.
|
薛凱中(Kai-Chung Hsueh); 林應如(Ying-Ju Lin); 張正成(Jeng-Sheng Chang); 萬磊(Lei Wan); 蔡育勳(Yuhsin Tsai); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-06 |
Asymmetric Chitosan Membrane Containing Collagen I Nanospheres for Skin Tissue Engineering
|
(Kuo-Yu Chen); (Wei-Ju Liao); (Shyh-Ming Kuo); 蔡輔仁(Fuu-Jen Tsai); 陳悅生(Yueh-Sheng Chen)*; 黃志揚(Chih-Yang Huang)*; 姚俊旭(Chun-Hsu Yao)* |
| 中國醫藥大學 |
2009-06 |
Activated of Insulin-Like Growth Factor ⅡReceptor Induces Mitochondria-dependent Apoptosis through Gαq and Downstream Calcineurin Signaling in Myocardial Cells
|
(Chun-Hsien Chu); (Bor-Show Tzang); (Li-Ming Chen); (Chung-Jung Liu); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 林子恩(Lin, Tzu-En); 郭薇雯(Wei-Wen Kuo); 包大(Da-Tian Bau)*; 姚俊旭(Chun-Hsu Yao)*; 黃志揚(Chih-Yang Huang)* |
| 中國醫藥大學 |
2009-06 |
Proliferation- and migration-enhancing effects of ginseng and ginsenoside Rg1 through IGF-I- and FGF-2-signaling pathways on RSC96 Schwann cells
|
呂明進(Ming-Chin Lu); 賴東淵(Tung-Yuan Lai); (Jin-Ming Hwang); 陳賢德(Hsien-Te Chen); (Sheng-Huang Chang); 蔡輔仁(Fuu-Jen Tsai); (Hwai-Lee Wang); 林建仲(Chien-Chung Lin)*; 郭薇雯(Wei-Wen Kuo)*; 黃志揚(Chih-Yang Huang)* |
| 中國醫藥大學 |
2009-06 |
Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis
|
鄭隆賓(Long-Bin Jeng)*; 羅婉瑜(Wan-Yu Lo); 許維儀(Wei-Yi Hsu); 林瑋德(Wei-De Lin); 林炯璁(Chiung-Tsung Lin); 賴建成(Chien-Chen Lai); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-05 |
Functional genomic analysis identified EGFR activation as the most common genetic event in oral squamous cell carcinoma
|
許晉銓(Jinn-Chyuan Sheu); 花俊宏(Chun-Hung Hua); 萬磊(Lei Wan); 林應如(Ying-Ju Lin); 賴銘淙; 曾憲彰(Hsien-Chang Tseng); (Jinawath N); 蔡銘修(Ming-Hsui Tsai); 張乃文(Nai-Wen Chang); 林錦芬(Lin, Chin-Fen); 林齊強(Chyi-Chyang Lin); 謝麗嬌(Hsieh LJ); (Wang TL); (Shih IeMing)*; 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-05 |
ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells
|
(Yi-Chang Cheng); 郭薇雯(Wei-Wen Kuo); (Hsi-Chin Wu); 賴東淵(Tung-Yuan Lai); (Jin-Ming Hwang); (Wen-Hung Wang); 蔡輔仁(Fuu-Jen Tsai); (Jaw-Ji Yang)*; 黃志揚(Chih-Yang Huang)*; (Chun-Hsien Chu)* |
| 中國醫藥大學 |
2009-05 |
The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system
|
(Ming-Chang Chiang); (Hui-Mei Chen); (Hsing-Lin Lai); (Hsiao-Wen Chen); (Szu-Yi Chou); (Chiung-Mei Chen); 蔡輔仁(Fuu-Jen Tsai); (YiJuang Chern)* |
| 中國醫藥大學 |
2009-04-25 |
FOXL2 mutations in Taiwanese patients with blepharophimosis-ptosis-epicanthus inversus syndrome
|
周宜卿(I-Ching Chou); 林瑋德(Wei-De Lin); 李妮鐘(Ni-Chung Lee); 王仲興(Chung-Hsing Wang); 郭煌宗(Haung-Tsung Kuo); 蔡長海(Chang-Hai Tsai); 林炫沛(Shuan-Pei Lin); 趙美琴(Mei-Chyn Chao); 胡務亮(Wuh-Liang Hwu); 周宜卿(I-Ching Chou); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-04 |
Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray. ionization tandem mass spectrometry
|
許維儀(Wei-Yi Hsu); 陳自諒(William Tzu-Liang Chen); 林瑋德(Wei-De Lin); 蔡輔仁(Fuu-Jen Tsai); 蔡育勳(Yuhsin Tsai); 林炯璁(Chiung-Tsung Lin); 羅婉瑜(Wan-Yu Lo); 鄭隆賓(Long-Bin Jeng)*; 賴建成(Chien-Chen Lai)* |
| 中國醫藥大學 |
2009-04 |
Novel human pathological mutations-Gene symbol:COMP-Disease: Pseudoachondroplasia
|
王仲興(Chung-Hsing Wang); 林瑋德(Wei-De Lin); 蔡俊慧; 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-04 |
Transforming growth factor-β1 increases cell migration and β1 integrin up-regulation in human lung cancer cells
|
馮逸卿(Yi-Chin Fong); 許昇峰(Sheng-Feng Hsu); 吳建林(Chien-Lin Wu); 李德茂(Te-Mao Li); 高尚德(Shung-Te Kao); 蔡輔仁(Fuu-Jen Tsai); 陳汶吉(Chen Wen-Chi); 劉軒誌(Shan-Chi Liu); 吳啟銘(Chi-Ming Wu); 湯智昕(Tang Chih-Hsin)* |
| 中國醫藥大學 |
2009-04 |
Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry
|
許維儀(Wei-Yi Hsu); 陳自諒(William Tzu-Liang Chen); 林瑋德(Wei-De Lin); 蔡輔仁(Fuu-Jen Tsai); 蔡育勳(Yuhsin Tsai); 林炯璁(Chiung-Tsung Lin); 羅婉瑜(Wan-Yu Lo); 鄭隆賓(Long-Bin Jeng)*; 賴建成(Chien-Chen Lai)* |
| 中國醫藥大學 |
2009-04 |
Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells
|
馮逸卿(Yi-Chin Fong);許昇峰(Sheng-Feng Hsu);吳建林(Wu Chien-Lin);李德茂(Te-Mao Li);高尚德(Shung-Te Kao);蔡輔仁(Fuu-Jen Tsai);陳汶吉(Chen, Wen-Chi);劉軒誌(Liu Shan-Chi);吳啟銘(Wu Chi-Ming);湯智昕(Tang Chih-Hsin)* |
| 中國醫藥大學 |
2009-03-21 |
A Study of the Interaction Between Tumor Susceptibility Gene GNMT and Environmental Carcinogens Polycyclic Aromatic Hydrocarbons
|
陳世殷(Shih-Yin, Chen)*; 萬磊(Lei Wan); 林應如(Ying-Ju Lin); 許晉銓(Jinn-Chyuan Sheu); 藍郁青(Yu-Ching Lan); 黃毓銓(Yu-Chuen Huang); 劉詩平(Shih-Ping Liu); 陳宜民(Yi-Ming Arthur Chen); 蔡輔仁(Fuu-Jen Tsai); 陳世殷(Shih-Yin, Chen); 陳世殷(Shih-Yin, Chen) |